Related references
Note: Only part of the references are listed.DUB3 deubiquitinates and stabilizes NRF2 in chemotherapy resistance of colorectal cancer
Qi Zhang et al.
CELL DEATH AND DIFFERENTIATION (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast Cancer
Daniel Davila-Gonzalez et al.
CLINICAL CANCER RESEARCH (2018)
Ubiquitin ligases in oncogenic transformation and cancer therapy
Daniela Senft et al.
NATURE REVIEWS CANCER (2018)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2017)
Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer
Yu Kang et al.
CLINICAL CANCER RESEARCH (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Deubiquitination and Stabilization of PD-L1 by CSN5
Seung-Oe Lim et al.
CANCER CELL (2016)
Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy
Jiliang Shen et al.
CANCER MEDICINE (2016)
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Styliani Karanika et al.
MOLECULAR CANCER (2015)
K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8+ T cell activation
Mingjin Yang et al.
NATURE IMMUNOLOGY (2015)
USP33 mediates Slit- Robo signaling in inhibiting colorectal cancer cell migration
Zhaohui Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Small GTPase RBJ Mediates Nuclear Entrapment of MEK1/MEK2 in Tumor Progression
Taoyong Chen et al.
CANCER CELL (2014)
Emerging Potential of Therapeutic Targeting of Ubiquitin-Specific Proteases in the Treatment of Cancer
Anupama Pal et al.
CANCER RESEARCH (2014)
DUSP1 Phosphatase Regulates the Proinflammatory Milieu in Head and Neck Squamous Cell Carcinoma
Xiaoyi Zhang et al.
CANCER RESEARCH (2014)
Nanoways to overcome docetaxel resistance in prostate cancer
Aditya Ganju et al.
DRUG RESISTANCE UPDATES (2014)
DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine
Fang Liu et al.
PLOS ONE (2014)
USP33, a new player in lung cancer, mediates Slit-Robo signaling
Pushuai Wen et al.
PROTEIN & CELL (2014)
Castration-Resistant Prostate Cancer: AUA Guideline
Michael S. Cookson et al.
JOURNAL OF UROLOGY (2013)
USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110
Ji Li et al.
NATURE (2013)
Malate dehydrogenase 2 confers docetaxel resistance via regulations of JNK signaling and oxidative metabolism
Qiong Liu et al.
PROSTATE (2013)
Clinical development of novel therapeutics for castration-resistant prostate cancer Historic Challenges and Recent Successes
Matthew D. Galsky et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Deubiquitinases in cancer: new functions and therapeutic options
J. M. Fraile et al.
ONCOGENE (2012)
Overcoming docetaxel resistance in prostate cancer: a perspective review
Clara Hwang
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2012)
Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries
Tammy L. Romanuik et al.
BMC GENOMICS (2009)
The deubiquitinases USP33 and USP20 coordinate β2 adrenergic receptor recycling and resensitization
Magali Berthouze et al.
EMBO JOURNAL (2009)
Targeting the ubiquitin system in cancer therapy
Daniela Hoeller et al.
NATURE (2009)
The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon
Chen Wang et al.
NATURE IMMUNOLOGY (2009)
Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration
Junichi Yuasa-Kawada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Dual-specificity MAP kinase phosphatases (MKPs) and cancer
Stephen M. Keyse
CANCER AND METASTASIS REVIEWS (2008)
Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma
Diego F. Calvisi et al.
CANCER RESEARCH (2008)
Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance
George W. Small et al.
CANCER RESEARCH (2007)
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer
S. Chattopadhyay et al.
ONCOGENE (2006)
Mechanism and function of deubiquitinating enzymes
AY Amerik et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer
HY Wang et al.
CANCER LETTERS (2003)
Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein
ZB Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
